(NASDAQ: QURE) Uniqure Nv's forecast annual revenue growth rate of 178.13% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.55%, and it is also forecast to beat the US market's average forecast revenue growth rate of 13.46%.
Uniqure Nv's revenue in 2026 is $16,098,000.On average, 16 Wall Street analysts forecast QURE's revenue for 2026 to be $2,276,320,569, with the lowest QURE revenue forecast at $643,427,608, and the highest QURE revenue forecast at $9,133,045,332. On average, 12 Wall Street analysts forecast QURE's revenue for 2027 to be $11,267,799,322, with the lowest QURE revenue forecast at $1,605,505,080, and the highest QURE revenue forecast at $23,591,720,344.
In 2028, QURE is forecast to generate $22,099,768,669 in revenue, with the lowest revenue forecast at $8,801,639,470 and the highest revenue forecast at $38,892,666,482.